Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Addiction Treatment in Russia: Oral vs. Naltrexone Implant [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing oral treatment with a naltrexone implant for heroin dependence and opioid-related disorders completed; results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone implant (naltrexone implant)

Snippet

Sponsor: University of Pennsylvania | Conditions: Heroin Dependence, Opioid-Related Disorders | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-02-27